Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems
Ageing Research Reviews · 2025
DOI: 10.1016/j.arr.2025.102695 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025. Verfasst von Piul Rabbani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hansjorg Wyss Department of Plastic Surgery, New York University Langone Health, New York, NY, USA. Hauptthemen laut MEDLINE: Aging, Adenosine, Receptors, Purinergic P1, Cardiovascular System. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, Miami Clinical and Translational Science Institute, University of Miami.
Abstract (Originalsprache)
Aging populations worldwide face an increasing burden of age-related chronic conditions, necessitating a deeper understanding of the underlying mechanisms. Purine metabolism has emerged as a crucial player in the pathophysiology of aging, affecting various tissues and organs. Dysregulation of purine metabolism, particularly alterations in extracellular adenosine levels and adenosine receptor signaling, contributes to age-related musculoskeletal problems, cardiovascular diseases, inflammation, and impaired immune responses. Changes in purine metabolism are associated with diminished tissue repair and regeneration, altered bone density, and impaired muscle regeneration. Mechanistically, age-related alterations in purine metabolism involve reductions in extracellular adenosine production, impaired autocrine signaling, and dysregulated expression of CD73 and CD39. Targeting adenosine receptors, such as A2A and A2B receptors, emerges as a promising therapeutic approach to mitigate age-related conditions, including sarcopenia, obesity, osteoarthritis, and impaired wound healing. Since we cannot reverse time, understanding the intricate molecular interplay between purine metabolism and aging-related pathologies holds significant potential for developing novel therapeutic strategies to improve the health and quality of life of aging populations. In this review, we compile the findings related to purine metabolism during aging in several tissues and organs and provide insights into how these signals can be manipulated to circumvent the deleterious effects of the passage of time on our body.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hansjorg Wyss Department of Plastic Surgery, New York University Langone Health, New York, NY, USA.
- Division of Vascular Surgery, Department of Surgery, New York University Langone Health, New York, NY, USA; Department of Cell Biology, New York University Langone Health, New York, NY, USA.
- Department of Medicine, Divisions of Rheumatology and Precision Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA. Electronic address: bruce.cronstein@nyulangone.org.
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- Miami Clinical and Translational Science Institute, University of Miami
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Heart Lung and Blood Institute Division of Intramural Research
- National Center for Advancing Translational Sciences
Zitieren
APA
Rabbani, P., Ramkhelawon, B., & Cronstein, B. N. (2025). Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102695
Vancouver
Rabbani P, Ramkhelawon B, Cronstein BN. Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems. Ageing Research Reviews. 2025. doi:10.1016/j.arr.2025.102695
BibTeX
@article{Rabbani2025,
author = {Rabbani, Piul and Ramkhelawon, Bhama and Cronstein, Bruce N},
title = {Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems},
journal = {Ageing Research Reviews},
year = {2025},
doi = {10.1016/j.arr.2025.102695}
}
EUVIMED